Peptide Hubs (71 Offers)

CLASSIFICATION: GROWTH HORMONE RELEASING PEPTIDE
ACTIVE SUBSTANCE: GHRP-2
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: 30 MINUTES
DOSAGE: 100–300 MCG 1–3X DAILY (RESEARCH USE)
ACNE: POSSIBLE
WATER RETENTION: MILD TO MODERATE
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: GROWTH HORMONE RELEASING PEPTIDE
ACTIVE SUBSTANCE: GHRP-2
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: APPROX. 30 MINUTES
DOSAGE: 100–300 MCG PER INJECTION (RESEARCH USE)
ACNE: POSSIBLE
WATER RETENTION: MILD
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: GROWTH HORMONE RELEASING PEPTIDE
ACTIVE SUBSTANCE: GHRP-6
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: APPROX. 30 MINUTES
DOSAGE: 100–300 MCG 1–3X DAILY (RESEARCH USE)
ACNE: POSSIBLE
WATER RETENTION: MILD
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: GROWTH HORMONE RELEASING PEPTIDE
ACTIVE SUBSTANCE: GHRP-6
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: APPROX. 30 MINUTES
DOSAGE: 100–300 MCG PER INJECTION (RESEARCH USE)
ACNE: POSSIBLE
WATER RETENTION: MILD
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: GONADOTROPIN-RELEASING HORMONE (GNRH) ANALOG
ACTIVE SUBSTANCE: GONADORELIN
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: 2–4 MINUTES
DOSAGE: 100–500 MCG PER DOSE (RESEARCH USE)
ACNE: UNLIKELY
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE
ACTIVE SUBSTANCE: EXAMORELIN (HEXARELIN)
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: APPROX. 55 MINUTES
DOSAGE: 100–200 MCG 1–2X DAILY (RESEARCH USE)
ACNE: UNLIKELY
WATER RETENTION: MILD
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: MITOCHONDRIAL-DERIVED PEPTIDE (MDP)
ACTIVE SUBSTANCE: HUMANIN
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: 16–24 HOURS (ESTIMATED)
DOSAGE: 1–10 MG/WEEK (RESEARCH USE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: GNRH SECRETAGOGUE PEPTIDE
ACTIVE SUBSTANCE: KISSPEPTIN-10
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: APPROX. 1 HOUR
DOSAGE: 100–500 MCG/DAY (RESEARCH USE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: ANTIOXIDANT PEPTIDE
ACTIVE SUBSTANCE: L-GLUTATHIONE
FORM: LYOPHILIZED POWDER (2 ML VIAL x 600 MG)
ACTIVE HALF-LIFE: APPROX. 1.5 HOURS
DOSAGE: 600–1200 MG/WEEK (RESEARCH USE)
ACNE: UNLIKELY
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: CYTOKINE PEPTIDE
ACTIVE SUBSTANCE: LIVAGEN
FORM: LYOPHILIZED POWDER (2 ML VIAL x 20 MG)
ACTIVE HALF-LIFE: 2–6 HOURS
DOSAGE: 10–20 MG/WEEK (RESEARCH USE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: ANTIMICROBIAL PEPTIDE (AMP)
ACTIVE SUBSTANCE: LL-37
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: APPROX. 1–2 HOURS
DOSAGE: 100–500 MCG/DAY (RESEARCH USE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: MECHANO GROWTH FACTOR (MGF) PEPTIDE
ACTIVE SUBSTANCE: MGF IGF-1 EC
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: APPROX. 5–7 MINUTES (NATIVE), 20–30 MINUTES (PEG-MODIFIED)
DOSAGE: 200–400 MCG PER INJECTION (RESEARCH USE)
ACNE: NO
WATER RETENTION: MILD (RARE)
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: GROWTH HORMONE RELEASING HORMONE (GHRH) ANALOG
ACTIVE SUBSTANCE: MOD GRF (CJC-1295 WITHOUT DAC)
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: APPROX. 30 MINUTES
DOSAGE: 100–200 MCG PER INJECTION (RESEARCH USE)
ACNE: NO
WATER RETENTION: MILD (RARE)
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: MITOCHONDRIAL-DERIVED PEPTIDE (MDP)
ACTIVE SUBSTANCE: MOTS-C
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: APPROX. 3 HOURS
DOSAGE: 5–15 MG/WEEK (RESEARCH USE)
ACNE: NO
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: PINEAL PEPTIDE / EPITHALON ANALOG
ACTIVE SUBSTANCE: N-ACETYL EPITHALON AMIDATE
FORM: LYOPHILIZED POWDER (2 ML VIAL x 20 MG)
ACTIVE HALF-LIFE: APPROX. 6–8 HOURS
DOSAGE: 5–20 MG/WEEK (RESEARCH USE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS

CLASSIFICATION: NOOTROPIC / ANXIOLYTIC PEPTIDE
ACTIVE SUBSTANCE: N-ACETYL SELANK AMIDATE
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: 7–10 HOURS
DOSAGE: 100–400 MCG/DAY (RESEARCH USE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS